$31.84
-0.94 (-2.87%)
Performance
1D
—
1W
—
1M
—
3M
-25.06%
6M
-4.78%
1Y
-5.49%
YTD
-24.89%
Open$32.52
Previous Close$32.78
Day High$32.78
Day Low$31.78
52W High$50.71
52W Low$22.61
Volume—
Avg Volume1.04M
Market Cap2.76B
P/E Ratio41.57
EPS$0.81
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$40.85
Below
SMA 200
$34.09
Below
RSI (14)
37.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
+47.1% upside
Current
$31.84
$31.84
Target
$46.85
$46.85
$30.44
$46.85 avg
$57.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 514.33M | 427.29M | 507.99M |
| Net Income | 65.99M | 49.34M | -2,027,984 |
| Profit Margin | 12.8% | 12.2% | -0.4% |
| EBITDA | 59.09M | 46.64M | -2,983,128 |
| Free Cash Flow | — | — | -1,866,923 |
| Rev Growth | +20.4% | +20.4% | +16.6% |
| Debt/Equity | — | — | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |